Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,699.38
(
1.01%
)
US TECH 100
23,886.80
(
-0.53%
)
Dow Jones
46,946.41
(
0.83%
)
Brent Oil
101.34
(
3.09%
)
Bitcoin
74,390.13
(
-0.61%
)
News Focus
News Focus
Post# of 257250
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122790
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 118658

Sunday, 04/24/2011 9:44:42 PM

Sunday, April 24, 2011 9:44:42 PM

Post# of 257250
Re: BG-12 safety record

BIIB’s two fumaric-acid derivates—BG-12 and Fumaderm—are not identical. The difference is that Fumaderm* contains both dimethyl fumarate and monoethyl fumarate, while BG-12 contains dimethyl fumarate only. This distinction probably isn’t consequential from a safety standpoint, but I don’t think one can say for sure.

This post was prompted by an assertion on another board that BG-12 has a longstanding safety record, which is not quite correct.

*Approved in Germany for psoriasis.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now